Sjögren's syndrome: Infections that may play a role in pathogenesis, mimic the disease, or complicate the patient's course

Indian Journal of Rheumatology

Volumn 6, Issue 1, 2011, Pages 13-25

  Fox, Robert I ^a   Fox, Carla M ^a  

^a SCRIPPS MEMORIAL HOSPITAL   (United States)

Author keywords

infections; Sjogren's syndrome

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BCG VACCINE; CHICKENPOX VACCINE; CHOLERA VACCINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA A ANTIGEN; HLA B ANTIGEN; HLA D ANTIGEN; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; METHOTREXATE; ORAL POLIOMYELITIS VACCINE; SMALLPOX VACCINE; TYPHOID VACCINE; VARICELLA ZOSTER VACCINE; YELLOW FEVER VACCINE;

AIDS RELATED COMPLEX; CANDIDA; CHICKENPOX; CHOLERA; CLINICAL FEATURE; COXSACKIE VIRUS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HEREDITY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION; INFLAMMATION; INFLUENZA; LACRIMAL GLAND; LEPROSY; MEASLES; MUMPS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARANEOPLASTIC SYNDROME; PATHOGENESIS; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; RUBELLA; SALIVARY GLAND; SJOEGREN SYNDROME; SMALLPOX; SYPHILIS; TRACHOMA; TREPONEMA PALLIDUM; TUBERCULOSIS; TYPHOID FEVER; VACCINATION; VARICELLA ZOSTER VIRUS; VIRAL TROPISM; VIRUS INFECTION; YELLOW FEVER;

EID: 84992240367     PISSN: 09733698     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0973-3698(11)60046-0     Document Type: Review

References (98)

1. Bolstad AI, Haga HJ, Wassmuth R, Jonsson R. Monozygotic twins with primary Sjogren's syndrome. J Rheumatol 2000; 27: 2264-6.
2. Deafen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311-8.
3. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005; 52: 1534-44. (Pubitemid 40663945)
4. Tan E, Muro Y, Pollard K. Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions. Clin Exp Rheumatol 1994; 12: S27-31.
5. Bolstad AI, Jonsson R. The role of apoptosis in Sjögren's syndrome. Ann Med Interne (Paris) 1998; 149: 25-9.
6. Maruyama T, Saito I, Hayashi Y, Kompfner E, Fox RI, Burton DR, et al. Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity. Am J Pathol 2004; 165: 53-61. (Pubitemid 38821813)
7. Singh AK. Lupus in the Fas lane? J R Coll Physicians Lond 1995; 29: 475-8.
8. Fox RI. Sjögren's syndrome. Lancet 2005; 366: 321-31.
9. Arnett F. Histocompatibility typing in the rheumatic diseases: diagnostic and prognostic implications. Med Clin NA 1994; 20: 371-87.
10. Arnett FC, Hamilton RG, Reveille JD, Bias WB, Harley JB, Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 1989; 32: 413-9. (Pubitemid 19118667)
11. Harley J, Reichlin M, Arnett F, Alexander EL, Bias W, Provost T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 1986; 232: 1145-7. (Pubitemid 16050805)
12. Adebajo A, Charles P, Maini R, Hazleman B. Autoantibodies in malaria, tuberculosis and hepatitis B in a West African population. Clin Exp Immunol 1993; 92: 73-6. (Pubitemid 23113902)
13. Petchclai B, Chuthanondh R, Rungruong S. Autoantibodies in leprosy among Thai patients. Lancet 1973; 301: 1481-2.
14. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5. (Pubitemid 20349249)
15. Churchill M, Geraci J, Hunder G. Musculoskeletal manifestations of bacterial endocarditis. Ann Intern Med 1977; 87: 754.
16. Fox RI. Epidemiology, pathogenesis, animal models, and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1994; 6: 501-8. (Pubitemid 24284898)
17. Fox RI, Chilton T, Scott S, Benton L, Howell FV, Vaughan JH. Potential role of Epstein-Barr virus in Sjögren's syndrome. Rheum Dis Clin North Am 1987; 13: 275-92.
18. Fox RI, Luppi M, Kang H-I, Pisa P. Reactivation of Epstein-Barr virus in Sjögren's syndrome. In: JW Sixbey TO, editor. Springer Seminar in Immunopathology. Heidelberg: Springer-Verlag, 1991: 217-31.
19. Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci 1994; 35: 3493-504. (Pubitemid 24337956)
20. Saito I, Servenius B, Compton T, Fox R. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 1989; 169: 2191-8. (Pubitemid 19162976)
21. Merne ME, Syrjanen SM. Detection of Epstein-Barr virus in salivary gland specimens from Sjögren's syndrome patients. Laryngoscope 1996; 106(12 Pt 1): 1534-9. (Pubitemid 26415265)
22. Karameris A, gorgoulis V, Iliopoulos A, Frangia C, et al. Detection of the Epstein-Barr viral genome by an in situ hybridization method in salivary gland biopsies from patients with secondary Sjögren's syndrome. Clin Exp Rheumatol 1992; 10: 327-32.
23. Kudo I, Saito I, Moro I. Detection of Epstein-Barr virus DNA from lacrimal gland biopsies in Sjögren's syndrome patients. Clin Exp Rheum 1991; 9: 337.
24. Pflugfelder SC, Crouse C, Pereira I, Atherton S. Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjögren's syndrome patients. Ophthalmology 1990; 97: 976-84. (Pubitemid 20251124)
25. Mariette X. Sjögren's syndrome and virus. Ann Med Interne (Paris) 1995; 146: 243-6.
26. Mariette X, Cazals-Hatem D, Agbalika F, Selimi F, Brunet M, Morinet F, et al. Absence of cytomegalovirus and Epstein-Barr virus expression in labial salivary glands of patients with chronic graft-versus-host disease. Bone Marrow Transplant 1996; 17: 607-10. (Pubitemid 26125714)
27. Tateishi MS, Saito I, Yamamoto K, Miyasaka N. Spontaneous production of Epstein Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren's syndrome. Arthritis Rheum 1993; 36: 827-35.
28. Vaughan JH, Nguyen MD, Valbracht JR, Patrick K, Rhodes GH. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and non-mimicking epitopes. Presence in autoimmune disease. J Clin Invest 1995; 95: 1316-27.
29. Fox RI, Luppi M, Kang HI, Pisa P. Reactivation of Epstein-Barr virus in Sjögren's syndrome. Springer Semin Immunopathol 1991; 13: 217-31.
30. Inoue N, Miyasaka N, Harada S, Yanagi K. Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis. J Infect Dis 1991; 164: 22-8.
31. Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. J Autoimmun 1994; 7: 179-91. (Pubitemid 24182436)
32. Miyasaka N, Saito I, Haruta J. Possible involvement of Epstein-Barr virus in the pathogenesis of Sjögren's syndrome. Clin Immunol Immunopathol 1994; 72: 166-70. (Pubitemid 24259429)
33. Yamazaki M, Kitamura R, Kusano S, Eda H, Sato S, Okawa-Takatsuji M, et al. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements. Clin Exp Immunol 2005; 139: 558-68. (Pubitemid 40340156)
34. Gaston JS, Rowe M, Bacon P. Sjögren's syndrome after infection by Epstein-Barr virus. J Rheumatol 1990; 17: 558-61. (Pubitemid 20152213)
35. Horiuchi M, Yamano S, Inoue H, Ishii J, Nagata Y, Adachi H, et al. Possible involvement of IL-12 expression by Epstein-Barr virus in Sjögren syndrome. J Clin Pathol 1999; 52: 833-7. (Pubitemid 29524946)
36. Fox RI, Luppi M, Pisa P, Kang HI. Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis. J Rheumatol Suppl 1992; 32: 18-24.
37. Eguchi K, Matsuoka N, Ida H, Nakashima M, et al. Primary Sjögren's syndrome with antibodies to HTLV-1: clinical and laboratory features. Ann Rheum Dis 1992; 51: 769-76.
38. Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature 1989; 341: 72-4. (Pubitemid 19220661)
39. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet 1994; 344: 1116-9.
40. Garry RF. New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases. Arthritis Rheum 1994; 37: 465-9. (Pubitemid 24115931)
41. Garry R, Fermin C, Hart D, Alexander S, Donehower L, Luo-Zhang H. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990; 250: 1127.
42. Fierabracci A, Upton CP, Hajibagheri N, Bottazzo GF. Lack of detection of retroviral particles (HIAP-1) in the H9 T cell line co-cultured with thyrocytes of Graves' disease. J Autoimmun 2001; 16: 457-62. (Pubitemid 32579008)
43. Kalden JR, Gay S. Retroviruses and autoimmune rheumatic diseases. Clin Exp Immunol 1994; 98: 1-5. (Pubitemid 24315442)
44. Zucker-Franklin D. Non-HIV retroviral associations with rheumatic disease. Curr Rheumatol Rep 2000; 2: 156-62.
45. Perl A. Endogenous retroviruses in pathogenesis of autoimmunity. J Rheumatol 2001; 28: 461.
46. Kim H, Takenaka O, Crow T. Cloning and nucleotide sequence of retroposons specific to hominoid primates derived from an endogenous retrovirus (HERV-K). AIDS research and human retroviruses. 1999; 15: 595-601. (Pubitemid 29177856)
47. Kjellman C, Sjögren HO, Salford LG, Widegren B. HERV-F (XA34) is a full-length human endogenous retrovirus expressed in placental and fetal tissues. Gene 1999; 239: 99-107. (Pubitemid 29468771)
48. Hishikawa T, Ogasawara H, Kaneko H, Shirasawa T, Matsuura Y, Sekigawa I, et al. Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol 1997; 10: 137-47. (Pubitemid 27478670)
49. Li JM, Fan WS, Horsfall AC, Anderson AC, Rigby S, Larsson E, et al. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin Exp Immunol 1996; 104: 388-93. (Pubitemid 26170077)
50. Andersson G, Svensson A, Setterblad N, Rask L. Retroelements in the human MHC class II region. Trends Genet 1998; 14: 109-14. (Pubitemid 28153329)
51. Rigby S, Cooke S, Weeransing D he, Venables P. Absence of HTLV-1 tax in Sjögren's syndrome. Arthritis Rheum 1996; 39: 1609-10.
52. Shattles WG, Brookes SM, Venables PJ, Clark DA, Maini RN. Expression of anitgen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome. Clin Exp Immunol 1992; 89: 46-51.
53. Stathopoulou E, Routsias J, Stea E, Moutsopoulos H, Tzioufas A. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin Exp Immuno 2005; 141: 148-54. (Pubitemid 40904652)
54. Stathopoulou EA, Routsias JG, Stea EA, Moutsopoulos HM, Tzioufas AG. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin Exp Immunol 2005; 141: 148-54. (Pubitemid 40904652)
55. Gottenberg JE, Pallier C, Ittah M, Lavie F, Miceli-Richard C, Sellam J, et al. Failure to confirm coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum 2006; 54: 2026-8. (Pubitemid 43877956)
56. Coll J, Gambus G, Corominas J, Tomas S, Esteban JI, Guardia J. Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus infection. Ann Rheum Dis 1997; 56: 390-2. (Pubitemid 27305430)
57. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 8: 321-3.
58. Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H, et al. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Nat Acad Sci 1997; 94: 233-6.
59. Arrieta JJ, Rodriguez-Inigo E, Ortiz-Movilla N, Bartolome J, Pardo M, Manzarbeitia F, et al. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001; 158: 259-64.
60. De Re V, De Vita S, Gasparotto D, Marzotto A, Carbone A, Ferraccioli G, et al. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur J Immunol 2002; 32: 903-10. (Pubitemid 34257568)
61. Ramos-Casals M, Garcia-Carrasco M, Cervera R, Font J. Sjögrenís syndrome and hepatitis C virus. Clin Rheumatol 1999; 18: 93-100.
62. Fox RI. Sjögren's syndrome. Controversies and progress. Clin Lab Med 1997; 17: 431-44.
63. Fox RI. Sjögren's syndrome. Curr Opin Rheumatol 1995; 7: 409-16.
64. Akriviadis EA, Xanthakis I, Navrozidou C, Papadopoulos A. Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha. J Clin Gastroenterol 1997; 25: 612-8. (Pubitemid 28051597)
65. Buezo GF, Garcia-Buey M, Rios-Buceta L, Borque MJ, Aragues M, Dauden E. Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection. Int J Dermatol 1996; 35: 112-5. (Pubitemid 26075479)
66. Cardinali C, Gerlini G, Caproni M, Pimpinelli N, Fabbri P. Hepatitis C virus: a common triggering factor for both nodular vasculitis and Sjögren's syndrome? [letter]. Br J Dermatol 2000; 142: 187-9. (Pubitemid 30074502)
67. Unoki H, Moriyama A, Tabaru A, Masumoto A, Otsuki M. Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C. J Gastroenterol 1996; 31: 723-7. (Pubitemid 26345542)
68. Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998; 7: 275-9. (Pubitemid 28264006)
69. Mariette X. The hepatitis C virus and systemic diseases. Rev Rhum Engl Ed 1998; 65: 737-40.
70. Klemola E, Kaariainen L. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J 1965; 2: 1099.
71. Maitland N, Flint S, Scully C, Crean SJ. Detection of cytomegalovirus and Epstein-Barr virus in labial salivary glands in Sjögren's syndrome and non-specific sialadenitis. J Oral Pathol Med 1995; 24: 293-8.
72. Venables P, Ross M, Charles P, Melsom R, Griffiths P, Maini R. A seroepidemiological study of cytomegalovirus and Epstein-Barr virus in rheumatoid arthritis and sicca syndrome. Ann Rheum Dis 1985; 44: 742.
73. Newkirk M, Duffy K, Leclerc J, Lambert N, Shiroky J. Detection of cytomegalovirus, Epstein-Barr virus and herpes virus-6 in patients with rheumatoid arthritis with or without Sjögren's syndrome. Rheumatology 1994; 33: 317.
74. Fox RI, Saito I, Chan EK, Josephs S, Salahuddin SZ, Ahlashi DV, et al. Viral genomes in lymphomas of patients with Sjögren's syndrome. J Autoimmun 1989; 2: 449-55.
75. Itescu S, Brancato L, Buxbaum J, Gregersen P, Rizk C, Croxson T, et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 1990; 112: 3.
76. Savige J, Chang L, Horn S, Crowe S. Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994; 18: 205-11. (Pubitemid 24344809)
77. Anderson L, Cummings N, Asofsky R, Hylton M, Tarpley T Jr, Tomasi T Jr, et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome: natural history and response to treatment. Am J Med 1972; 53: 456-63.
78. Şoglu Y, Erdamar B, lhan, Katircioglu O, evikbas U. Tuberculosis of the parotid gland. J Laryngol Otol 2007; 112: 588-91.
79. Kim Y, Jeong W, Jung K, Sung M, Kim K, Kim C. Diagnosis of major salivary gland tuberculosis: experience of eight cases and review of the literature. Acta otolaryngologica 2005; 125: 1318-22. (Pubitemid 41721998)
80. Isenberg D, Maddison P, Swana G, Skinner R, Swana M, Jones M, et al. Profile of autoantibodies in the serum of patients with tuberculosis, klebsiella and other gram-negative infections. Clin Exp Immunol 1987; 67: 516.
81. Lindqvist K, Coleman R, Osterland C. Autoantibodies in chronic pulmonary tuberculosis. J Chronic Dis 1970; 22: 717-25.
82. Shoenfeld Y, Vilner Y, Coates A, Rauch J, Lavie G, Shaul D, et al. Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immuno 1986; 66: 255.
83. Southam J, Venkataraman B. Oral manifestations of leprosy. Br J Oral Surg 1973; 10: 272-9.
84. Sekhar G, Vance G, Otton S, Kumar S, Stanley J, Rao G. Ocular manifestations of Hansen's disease. Doc Ophthalmol 1994; 87: 211-21. (Pubitemid 24326966)
85. Dana M, Hochman M, Viana M, Hill C, Sugar J. Ocular manifestations of leprosy in a noninstitutionalized community in the United States. Arch Ophthalmol 1994; 112: 626.
86. Reichart P, Samaranayake L, Samaranayake Y, Grote M, Pow E, Cheung B. High oral prevalence of Candida krusei in leprosy patients in Northern Thailand. J Clin Microbiol 2002; 40: 4479.
87. Manley G, Wong E, Dalmau J, Elkon K, Posner J, Furneaux H. Sera from some patients with antibody-associated paraneoplastic encephalomyelitis/sensory neuronopathy recognize the Ro-52K antigen. J Neurooncol 1994; 19: 105-12. (Pubitemid 24252157)
88. Capra J, Winchester R, Kunkel H. Hypergammaglobulinemic purpura: studies on the unusual anti-[gamma]-globulins characteristic of the sera of these patients. Medicine 1971; 50: 125.
89. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. In: Elsevier, 2004: 355-74.
90. Miller D. The association of immune disease and malignant lymphoma. Ann Intern Med 1967; 66: 507.
91. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11: S45-53.
92. Petrovsky N, Aguilar J. Vaccine adjuvants: current state and future trends. Immunol Cell Biol 2004; 82: 488-96. (Pubitemid 39421058)
93. Colmegna I, Koehler J, Garry R, Espinoza L. Musculoskeletal and autoimmune manifestations of HIV, syphilis and tuberculosis. Curr Opin Rheumatol 2006; 18: 88.
94. Arrieta J, Rodriguez-Inigo E, Ortiz-Movilla N, BartolomÈ J, Pardo M, Manzarbeitia F, et al. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001; 158: 259.
95. Pawlotsky J, Yahia M, Andre C, Voisin M, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-8. (Pubitemid 24109343)
96. Trapani S, Einmini M, Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. In: Elsevier, 1999: 319-25.
97. Adebajo A. Dengue arthritis. Rheumatology 1996; 35: 909.
98. Yung R, Richardson B. Drug-induced lupus. Rheum Dis Clin North Am 1994; 20: 61.